Literature DB >> 22347833

Risk of lymphoma in patients with inflammatory bowel disease.

James D Lewis1.   

Abstract

Entities:  

Year:  2012        PMID： 22347833      PMCID： PMC3277199     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

1.  Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.

Authors:  A Kandiel; A G Fraser; B I Korelitz; C Brensinger; J D Lewis
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

2.  Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.

Authors:  Lisa J Herrinton; Liyan Liu; Xiaoping Weng; James D Lewis; Susan Hutfless; James E Allison
Journal:  Am J Gastroenterol       Date:  2011-10-25       Impact factor: 10.864

Review 3.  The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safety.

Authors:  Gert Van Assche; James D Lewis; Gary R Lichtenstein; Edward V Loftus; Qin Ouyang; Julian Panes; Corey A Siegel; William J Sandborn; Simon P L Travis; Jean-Frederic Colombel
Journal:  Am J Gastroenterol       Date:  2011-08-16       Impact factor: 10.864

4.  Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Authors:  Laurent Beaugerie; Nicole Brousse; Anne Marie Bouvier; Jean Frédéric Colombel; Marc Lémann; Jacques Cosnes; Xavier Hébuterne; Antoine Cortot; Yoram Bouhnik; Jean Pierre Gendre; Tabassome Simon; Marc Maynadié; Olivier Hermine; Jean Faivre; Fabrice Carrat
Journal:  Lancet       Date:  2009-11-07       Impact factor: 79.321

Review 5.  Safety profile of IBD: lymphoma risks.

Authors:  Meenakshi Bewtra; James D Lewis
Journal:  Gastroenterol Clin North Am       Date:  2009-12       Impact factor: 3.806
  5 in total
  2 in total

1.  Indolent T-cell lymphoproliferative disease of the gastrointestinal tract after treatment with adalimumab in resistant Crohn's colitis.

Authors:  Natalia Edison; Hila Belhanes-Peled; Yuval Eitan; Yifat Guthmann; Yelena Yeremenko; Mark Raffeld; Irit Elmalah; Philippe Trougouboff
Journal:  Hum Pathol       Date:  2016-07-08       Impact factor: 3.466

Review 2.  Epstein-Barr Virus: Diseases Linked to Infection and Transformation.

Authors:  Hem C Jha; Yonggang Pei; Erle S Robertson
Journal:  Front Microbiol       Date:  2016-10-25       Impact factor: 5.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.